SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-001501
Filing Date
2021-01-06
Accepted
2021-01-06 16:10:37
Documents
1
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211788-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm211788-2_4seq1.xml 4 10658
  Complete submission text file 0001104659-21-001501.txt   12144
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HALSEY DRUG CO INC 1827 PACIFIC STREET BROOKLYN NY 11233
Business Address
CLEMENS PETER A (Reporting) CIK: 0001056695 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 21510620